Applications including "Octadecyl"

LC094 - Analysis of Steroids -

LC InertSearch Inertsil Hybrid-C18
LC093 - Analysis of Phytosterols -

LC InertSearch Inertsil Hybrid-C18
LC092 - Analysis of Oligonucleotides -

LC InertSearch Inertsil Hybrid-C18
LC091 - Analysis of Oligonucleotides -

LC InertSearch Inertsil Hybrid-C18
LC090 - Analysis of Oligonucleotides -

LC InertSearch Inertsil Hybrid-C18
LC089 - Analysis of Nucleobases and Nucleosides -

LC InertSearch Inertsil Hybrid-C18
LC088 - Analysis of Nucleobases and Nucleosides -

LC InertSearch Inertsil Hybrid-C18
LC087 - Analysis of Coenzyme A (CoA) -

LC InertSearch Inertsil Hybrid-C18
LC086 - Analysis of Antiviral drugs -

LC InertSearch Inertsil Hybrid-C18
LC085 - Analysis of Antiviral drug nucleosides -

LC InertSearch Inertsil Hybrid-C18
LC084 - Analysis of Antihistamines -

LC InertSearch Inertsil Hybrid-C18
LC083 - Analysis of Antidepressants -

LC InertSearch Inertsil Hybrid-C18
LC082 - Analysis of phytosterols -

LC InertSearch InertCore Plus C18
LC073 - Analysis of Yohimbine Hydrochloride(Under the Condition of USP41-NF36,Yohimbine Injection, ASSAY) -

LC InertSearch InertSustain C18
LC072 - Analysis of Vitamin K１ (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PHYTONADIONE) -

LC InertSearch InertSustain C18
LC071 - Analysis of Acetaminophen(Under the Condition of USP41-NF36, Acetaminophen Oral Solution, ASSAY) -

LC InertSearch Inertsil WP300 C18
LC068 - Analysis of Gliclazide (Under the Condition of the draft for Japanese Pharmacopoeia, Gliclazide Tablets, ASSAY) -

LC InertSearch Inertsil WP300 C18
LC067 - Analysis of Rebamipide (Under the Condition of the Japanese Pharmacopoeia 18th, Rebamipide, Purity (4) Related Substances -

LC InertSearch Inertsil ODS-3
LC066 - Analysis of Cidofovir (Under the Condition of USP43-NF38, Cidofovir, ASSAY) -

LC InertSearch Inertsil Hybrid-C18
LC065 - Analysis of Vitamin E (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 1) -

LC InertSearch InertSustain C18
LC064 - Analysis of Pioglitazone Hydrochloride and Glimepiride (Under the Condition of the Japanese Pharmacopoeia 18th, Pioglitazone Hydrochloride and Glimepiride Tablets, ASSAY(2)Glimepiride) -

LC InertSearch InertSustainSwift C18
LC063 - Analysis of Pioglitazone Hydrochloride and Glimepiride (Under the Condition of the Japanese Pharmacopoeia 18th, Pioglitazone Hydrochloride and Glimepiride Tablets, ASSAY(1)Pioglitazone Hydrochloride) -

LC InertSearch InertSustainSwift C18
LC062 - Analysis of Azithromycin (Under the Condition of USP NF 2025 Issue 2 Mar, Azithromycin, DISSOLUTION) -

LC InertSearch Inertsil Hybrid-C18
LC061 - Analysis of Azithromycin (Under the Condition of USP NF 2025 Issue 2 Mar, Azithromycin,ASSAY) -

LC InertSearch Inertsil Hybrid-C18
LC060 - Analysis of Aspirin (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Aspirin Delayed-release Tablets, ASSAY) -

LC InertSearch InertSustain C18
LC059 - Analysis of 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Pregabalin, 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide, Assay) -

LC InertSearch InertSustain AQ-C18
LC058 - Analysis of Folic acid (Under the Condition of USP NF 2022 ISSUE 3, <411>FOLIC ACID ASSAY,_Procedure 1) -

LC InertSearch InertSustainSwift C18
LC057 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol Tablets, ASSAY) -

LC InertSearch InertSustain C18
LC056 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol, ASSAY) -

LC InertSearch InertSustain C18
LC055 - Analysis of Dobutamine (Under the Condition of the USPNF 2023 Issue 2, Dobutamine Hydrochloride, ASSAY) -

LC InertSearch Inertsil WP300 C18
LC054 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol Injection, ASSAY) -

LC InertSearch InertSustain C18
LC051 - Analysis of Vitamin C (Under the Condition of USP41-NF36, Vitamin C ASSAY,PROCEDURE 1) -

LC InertSearch InertSustain AQ-C18
LC050 - Analysis of Vitamin E (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 3) -

LC InertSearch Inertsil WP300 C18
LC049 - Analysis of Vitamin E (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 2) -

LC InertSearch InertSustain C18
LC047 - Analysis of Homocysteine -

LC InertSearch InertSustain AQ-C18
LC045 - Analysis of Catecholamines -

LC InertSearch Inertsil ODS-4
LC044 - Analysis of Calcium Pantothenate (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Calcium Pantothenate, Method1) -

LC InertSearch InertSustainSwift C18
LC043 - Analysis of Semaglutide and Tirzepatide -

LC InertSearch InertSustainSwift C18
LC041 - Analysis of Nicotinamide,Pyridoxine Hydrochloride,Riboflavin,and Thiamine hydrochloride_Method1 (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin or Niacinamide,Pyridoxine Hydrochloride,Riboflavin,and Thiamine_ Method1) -

LC InertSearch InertSustain C18
LC038 - Analysis of Brilliant Green and Methylene Blue -

LC InertSearch InertSustain C18
LC037 - Analysis of Amlodipine Besilate (Under the Condition of the Japanese Pharmacopoeia 18th, Amlodipine Besilate, Purity(2) Related Substances) -

LC InertSearch InertSustain C18
LC036 - Analysis of Zonisamide (Under the Condition of USP41-NF36, Zonisamide Compounded Oral Suspension, ASSAY) -

LC InertSearch InertSustain C18
LC035 - Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide Capsules, ASSAY) -

LC InertSearch InertSustain C18
LC034 - Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide, ASSAY) -

LC InertSearch InertSustain C18
LC033 - Analysis of D‐Biotin (Under the Condition of USP43-NF38, Oil- and Water-Soluble Vitamins Minerals Tablets,BIOTIN_Method 3) -

LC InertSearch InertSustain C18
LC029 - Analysis of Riboflavin (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,RIBOFLAVIN_Method 2) -

LC InertSearch InertSustain C18
LC028 - Analysis of Pyridoxine hydrochloride (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PYRIDOXINE HYDROCHLORIDE_Method 2) -

LC InertSearch InertSustain C18
LC027 - Analysis of Nicotinamide (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,NIACINAMIDE_Method 2) -

LC InertSearch InertSustain C18
LC026 - Analysis of Nicotinic acid (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin_Method 2) -

LC InertSearch InertSustain C18
LC025 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) -

LC InertSearch InertSustain AQ-C18
LC024 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone, ASSAY) -

LC InertSearch Inertsil ODS-3
LC023 - Analysis of Lansoprazole (Under the Condition of the USP41-NF36, Lansoprazole Compounded Oral Suspension, ASSAY) -

LC InertSearch InertSustain C18
LC022 - Analysis of Ursodeoxycholic acid (Under the Condition of the Japanese Pharmacopoeia 18th, Ursodeoxycholic acid Tablets, Ursodeoxycholic acid Granules) -

LC InertSearch InertSustain C18
LC021 - Analysis of Cyanocobalamin (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Cyanocobalamin_Method1) -

LC InertSearch Inertsil ODS-HL
LC019 - Analysis of Aspartame and L-α-Aspartyl-D-phenylalanine Methyl Ester -

LC InertSearch InertSustain C18
LC018 - Analysis of L-α-Aspartyl-D-phenylalanine Methyl Ester (Japan’s Standards and Specifications for Food Additives (10th ed.), Aspartame, Purity(5)) -

LC InertSearch InertSustain C18
LC017 - Analysis of Itraconazole (Under the Condition of Japanese Pharmacopoeia 18th, Itraconazole, Purity(2) Related substances) -

LC InertSearch InertSustain C18
LC016 - Analysis of Itraconazole (Under the Condition of USP-NF 2021 Issue 2, Itraconazole Capsules, ASSAY) -

LC InertSearch InertSustain C18
LC015 - Analysis of Itraconazole (Under the draft for USP, Itraconazole Oral Solution, ASSAY) -

LC InertSearch InertSustain C18
LC014 - Analysis of Itraconazole (Under the Condition of USP43-NF38, Itraconazole, ASSAY) -

LC InertSearch InertSustainSwift C18
LC013 - Analysis of Bleomycin sulfate -

LC InertSearch InertSustain AQ-C18
LC010 - Analysis of Imazalil (Under the Condition of food additive analysis method in food, Imazalil) -

LC InertSearch Inertsil ODS-3
LC009 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -

LC InertSearch Inertsil ODS-3
LC008 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -

LC InertSearch InertSustain C18
LC006 - Analysis of Benzoyl Peroxide（Under the Condition of food additive analysis method in food, Benzoyl peroxide) -

LC InertSearch Inertsil ODS-3
LC005 - Carbamazepine -

LC InertSearch InertSustainSwift C18
LC004 - Analysis of Urea and Thiourea -

LC InertSearch InertSustain AQ-C18
LC002 - Analysis of Phenazopyridine hydrochloride -

LC InertSearch InertSustain C18
LB991 - Analysis of Progestrone and Methyltestrone -

LC InertSearch Inertsil WP300 C18
LB990 - Analysis of Xylazine -

LC InertSearch Inertsil WP300 C18
LB989 - Analysis of Xylazine -

LC InertSearch InertSustain C18
LB988 - Analysis of Xylazine -

LC InertSearch InertSustainSwift C8
LB987 - Analysis of Xylazine -

LC InertSearch Inertsil WP300 C18
LB986 - Analysis of Ganciclovir -

LC InertSearch Inertsil ODS-3
LB985 - Analysis of Sumatriptan -

LC InertSearch Inertsil ODS-3
LB984 - Analysis of Sumatriptan -

LC InertSearch InertSustain AQ-C18
LB983 - Analysis of Lornoxicam -

LC InertSearch Inertsil ODS-4
LB982 - Analysis of Ofloxacin -

LC InertSearch InertSustain C18
LB981 - Analysis of Ofloxacin -

LC InertSearch Inertsil WP300 C18
LB980 - Analysis of Desloratadine -

LC InertSearch InertSustain AQ-C18
LB979 - Analysis of Desloratadine -

LC InertSearch InertSustain Cyano
LB978 - Analysis of Hydrochlorothiazide -

LC InertSearch InertSustain AQ-C18
LB977 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain AQ-C18
LB976 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain C18
LB975 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain C18
LB974 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain C18
LB973 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain C18
LB972 - Analysis of Acyclovir -

LC InertSearch InertSustain C18
LB971 - Analysis of Acyclovir -

LC InertSearch InertSustain C18
LB970 - Analysis of Acyclovir -

LC InertSearch InertSustain C18
LB969 - Analysis of Acyclovir -

LC InertSearch InertSustainSwift C18
LB968 - Analysis of Acyclovir -

LC InertSearch Inertsil WP300 C18
LB967 - Analysis of Difluoroacetic acid and Trifluoroacetic acid -

LC InertSearch InertSustain AQ-C18
LB962 - Analysis of β-carotene -

LC InertSearch InertSustainSwift C18
LB961 - Analysis of Lidocaine -

LC InertSearch Insertsil WP300 C18
LB960 - Analysis of Lidocaine -

LC InertSearch Insertsil WP300 C18
LB959 - Analysis of Food Dyes -

LC InertSearch InertSustainSwift C18
LB958 - Analysis of Methyltestosterone and Progesterone -

LC InertSearch Insertsil WP300 C18
LB954 - Analysis of Difluoroacetic acid and Trifluoroacetic acid -

LC InertSearch InertSustain AQ-C18
LB952 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets) -

LC InertSearch InertSustain C18
LB951 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Capsules) -

LC InertSearch InertSustain C18
LB950 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin) -

LC InertSearch InertSustain C18
LB949 - Analysis of Panose -

LC InertSearch Inertsustain NH2
LB947 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB946 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB945 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB944 - Analysis of Amikacin sulfate -

LC InertSearch InertSustainSwift C18
LB943 - Analysis of Amikacin -

LC InertSearch InertSustainSwift C18
LB942 - Analysis of Maleic acid -

LC InertSearch Inertsil ODS-4
LB941 - Analysis of Fumaric acid -

LC InertSearch Inertsil ODS-4
LB940 - Analysis of DL-Malic acid -

LC InertSearch InertSustain C18
LB938 - Analysis of Galantamine -

LC InertSearch InertSustain C18
LB937 - Analysis of Febuxostat -

LC InertSearch Inertsil ODS-4
LB935 - Analysis of Febuxostat -

LC InertSearch InertSustain AQ-C18
LB934 - Analysis of Methylpyrazines -

LC InertSearch InertSustain C18
LB933 - Analysis of Diclofenac sodium -

LC InertSearch Inertsil WP300 C18
LB932 - Analysis of 13 kinds of Aldehydes (Detected by Pre-Column Method with DNPH) -

LC InertSearch Inertsil ODS-HL
LB931 - Analysis of Acyclovir -

LC InertSearch Inertsil ODS-3
LB930 - Analysis of Blonanserin -

LC InertSearch InertSustain C18
LB929 - Analysis of Blonanserin -

LC InertSearch InertSustain C18
LB928 - Analysis of Blonanserin -

LC InertSearch InertSustain C18
LB927 - Analysis of Blonanserin -

LC InertSearch InertSustain C18
LB926 - Analysis of Piperacillin Sodium -

LC InertSearch Inertsil WP300 C18
LB922 - Analysis of 4 Drugs -

LC InertSearch InertSustai AQ-C18 InertSustain AQ-C18
LB921 - Analysis of 4 Drugs -

LC InertSearch Inertsil ODS-4
LB920 - Analysis of Triphenylphosphine oxide -

LC InertSearch InertSustain C18
LB919 - Analysis of Pitavastatin Calcium -

LC InertSearch InertCore Plus C18
LB918 - Analysis of d-α-Tocopheryl Acetate -

LC InertSearch InertSustain C18
LB917 - Analysis of 130 Pestisides -

LC InertSearch InertSustain C18
LB916 - Analysis of Metformin Hydrochloride -

LC InertSearch InertSustain C18
LB915 - Analysis of Metformin Hydrochloride -

LC InertSearch InertSustain C18
LB914 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB913 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB912 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB911 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB910 - Analysis of Fatty acids (C18-C26) -

LC InertSearch InertSustain AQ-C18
LB909 - Analysis of Fatty acids (C18-C26) -

LC InertSearch InertSustain AQ-C18
LB908 - Analysis of Fatty acids (C1-C18) -

LC InertSearch InertSustain AQ-C18
LB907 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB906 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB905 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB903 - Analysis of Perospirone hydrochloride -

LC InertSearch InertSustain C18
LB902 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB901 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB899 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustainSwift C18
GA355 - Analysis of Amines -

GC InertSearch InertCap 1
GA354 - Analysis of Amines -

GC InertSearch InertCap for Amines
LB898 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -

LC InertSearch InertSustain AQ-C18
LB897 - Analysis of Thiamine Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB896 - Analysis of Triptorelin Pamoate -

LC InertSearch InertSustain C18
LB894 - Analysis of Ursodiol -

LC InertSearch Inertsil WP300
LB893 - Analysis of PAHs -

LC InertSearch Inertsil ODS-P
LB892 - Analysis of Chlorophenols -

LC InertSearch InertSustain C18 HP
LB891 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB890 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB889 - Analysis of Propyl gallate -

LC InertSearch Inertsil WP300
LB888 - Analysis of Propyl gallate -

LC InertSearch Inertsil WP300
LB887 - Analysis of Propyl gallate -

LC InertSearch Inertsil ODS-4
LB886 - Analysis of Glyphosate,Mecoprop,Bromacil -

LC InertSearch InertSustain AX-C18
LB882 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch InertSustain C18
LB881 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB880 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch InertSustain C18
LB879 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB878 - Analysis of Mefenamic acid -

LC InertSearch InertSustain C18
LB877 - Analysis of Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB876 - Analysis of Cefoxitin -

LC InertSearch InertSustain C18
LB875 - Analysis of Levofloxacin -

LC InertSearch Inertsil ODS-3
LB874 - Analysis of Captopril and Captopril Disulfide -

LC InertSearch InertSustain AQ-C18
LB873 - Tacrolimus Extended-Release Capsules -

LC InertSearch InertSustain AQ-C18
LB868 - Analysis of Propionic Acid -

LC InertSearch InertSustain C18
LB867 - Analysis of Febuxostat -

LC InertSearch InertSustain C18
LB866 - Analysis of Sucralose -

LC InertSearch InertSustain C18
LB865 - Analysis of Water-soluble vitamins and D-Araboascorbic acid -

LC InertSearch InertSustain C18
LB864 - Analysis of Benzoic acid, Sorbic acid and Dehydroacetic acid -

LC InertSearch InertSustain C18
LB863 - Analysis of BHT_BHA_PG（Analytical Method A） -

LC InertSearch InertSustain C18
LB862 - Analysis of Antioxidants -

LC InertSearch InertSustain C18
LB860 - Analysis of Glycyrrhizinate acid -

LC InertSearch InertSustain C18
LB859 - Analysis of Amoxicillin and Clavulanate potassium -

LC InertSearch Inertsil ODS-3
LB858 - Analysis of Natamycin (Analytical Method B) -

LC InertSearch InertSustain C18
LB857 - Analysis of Natamycin (Analytical Method A) -

LC InertSearch InertSustain AQ-C18
LB855 - Analysis of 6 kinds of Aldehydes (Detected by Pre-Column Method with DNPH) -

LC InertSearch InertSustain C30
LB854 - Analysis of Naringin and Hesperidin -

LC InertSearch InertSustain AQ-C18
LB853 - Analysis of p-Hydroxybenzoic acid esters -

LC InertSearch InertSustain C18
LB852 - Analysis of Benzoic acid -

LC InertSearch InertSustain C18
LB851 - Analysis of Calcium Pantothenate -

LC InertSearch InertSustain AQ-C18
LB850 - Analysis of Ethylenediaminetetraacetic acid ferric sodium salt trihydrate -

LC InertSearch InertSustain C18
LB849 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LC InertSearch Inertsil ODS-4
LB848 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LC InertSearch Inertsil ODS-4
LB846 - Analysis of Tocopheryl acetate -

LC InertSearch InertSustain C18
LB845 - Analysis of L-Ascorbyl palminate and L-Ascorbic Stearate -

LC InertSearch InertSustain C18
LB836 - Analysis of Sudan dyes and Para red -

LC InertSearch Inertsil ODS-3
LB835 - Analysis of Sudan dyes and Para red -

LC InertSearch InertSustain C18
LB834 - Analysis of Paraoxybenzoic acid esters -

LC InertSearch InertSustain C18
LB833 - Analysis of Methyl Parahydroxybenzoate -

LC InertSearch InertSustain C18
LB832 - Analysis of Nordihydroguaiaretic Acid -

LC InertSearch InertSustain C18
LB831 - Analysis of Nordihydroguaiaretic Acid -

LC InertSearch InertSustain C18
LB830 - Analysis of Azoxystrobin -

LC InertSearch InertSustain C18
LB829 - Analysis of Sulfamethoxazole and Trimethoprim -

LC InertSearch Inertsil WP300 C18
LB828 - Analysis of Chloroprocaine Hydrochloride -

LC InertSearch InertSustain C18
LB827 - Analysis of Clobetasone butyrate standard -

LC InertSearch InertSustainSwift C18
LB819 - Analysis of ATP and Cyclic nucleotide (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB818 - Analysis of Nucleotides and Cyclic nucleotides -

LC InertSearch InertSustain AX-C18
LB809 - Analysis of ATP related compounds and Guanylic acid -

LC InertSearch InertSustain AQ-C18
LB806 - Analysis of Ampicillin and Sulbactam (Under the Condition of the Japanese Pharmacopoeia 18th , Ampicillin Sodium and Sulbactam Sodium for Injection) -

LC InertSearch Inertsil ODS-HL
LB805 - Analysis of nonvolatile amines (prelabel derivatization by Dansyl Chloride) -

LC InertSearch InertSustain C18
LB802 - Analysis of Sesamin -

LC InertSearch Inertsil ODS-HL
LB800 - Analysis of 1,3-Dicyclohexylurea -

LC InertSearch InertSustain C18
LB789 - Analysis of Oligonucleotides -

LC InertSearch InertSustain AX-C18
LB788 - Analysis of Oligonucleotides -

LC InertSearch InertSustain AX-C18
LB787 - Analysis of Oligonucleotides -

LC InertSearch InertSustain AX-C18
LB786 - Analysis of Oligonucleotides -

LC InertSearch InertSustain AX-C18
LB785 - Analysis of Uric Acid and its related compounds -

LC InertSearch InertSustain AX-C18
LB784 - Analysis of ATP and its related compounds -

LC InertSearch InertSustain AX-C18
LB783 - Analysis of UTP and its related compounds -

LC InertSearch InertSustain AX-C18
LB782 - Analysis of GTP and its related compounds -

LC InertSearch InertSustain AX-C18
LB781 - Analysis of CTP and its related compounds -

LC InertSearch InertSustain AX-C18
LB780 - Analysis of ATP and its related compounds -

LC InertSearch InertSustain AX-C18
LB779 - Analysis of Coenzyme A (CoA) -

LC InertSearch InertSustain AX-C18
LB778 - Analysis of Coenzyme A (CoA) -

LC InertSearch InertSustain AX-C18
LB777 - Analysis of Sugar Phosphates -

LC InertSearch InertSustain AX-C18
LB776 - Analysis of Sugar Phosphates -

LC InertSearch InertSustain AX-C18
LB775 - Analysis of Cyclic Nucleotide -

LC InertSearch InertSustain AX-C18
LB774 - Analysis of Nucleotide sugars -

LC InertSearch InertSustain AX-C18
LB773 - Analysis of Nicotinamide adenine dinucleotide and Nicotinamide adenine dinucleotide phosphate (NAD+, NADH, NADP+, NADPH) -

LC InertSearch InertSustain AX-C18
LB772 - Analysis of Nicotinamide adenine dinucleotide (NADH, NAD+) -

LC InertSearch InertSustain AX-C18
LB771 - Analysis of Nucleoside and Nucleic acid base -

LC InertSearch InertSustain AX-C18
LB770 - Analysis of Pyruvic acid and Phosphoenolpyruvic acid -

LC InertSearch InertSustain AX-C18
LB769 - Analysis of Thiamine and Thiamine pyrophosphate -

LC InertSearch InertSustain AX-C18
LB768 - Analysis of Low molecular weight Hyaluronic acid -

LC InertSearch InertSustain AX-C18
LB767 - Analysis of Chondroitin Sulfate -

LC InertSearch InertSustain AX-C18
LB766 - Analysis of Glucuronic acid -

LC InertSearch InertSustain AX-C18
LB765 - Analysis of Sialic acid -

LC InertSearch InertSustain AX-C18
LB764 - Analysis of Organic acids -

LC InertSearch InertSustain AX-C18
LB763 - Analysis of Tryptophan metabolites -

LC InertSearch InertSustain AX-C18
LB762 - Analysis of L-Cysteic acid -

LC InertSearch InertSustain AX-C18
LB761 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch Inertsil ODS-4
LB760 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain C18
LB759 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain AX-C18
LB758 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain C18
LB757 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LC InertSearch Inertsil ODS-4
LB756 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LC InertSearch Inertsil ODS-4
LB755 - Analysis of Oxaliplatin (Under the Condition of the draft for the Japanese Pharmacopoeia18th supplement II) -

LC InertSearch InertSustainSwift C18
LB754 - Analysis of Saccharin (Under the Condition of the Japanese Pharmacopoeia 18th, Saccharin Sodium Hydrate) -

LC InertSearch Inertsil WP300 C18
LT133 - How to Use Preparative HPLC - Part 1 Evaluation of loading amount -

LC Technical Note
LT124 - Analysis of Furfural in Insulating Oil -

LC Technical Note InertSustainSwift C18 InertSustain AQ-C18
GT047 - Easy and fast Enrichment of the Aroma Components of Cheese by MMSE -

GC Technical Note InertCap Pure-WAX

Applications including "Octadecyl"

LC094 - Analysis of Steroids -

LC093 - Analysis of Phytosterols -

LC092 - Analysis of Oligonucleotides -

LC091 - Analysis of Oligonucleotides -

LC090 - Analysis of Oligonucleotides -

LC089 - Analysis of Nucleobases and Nucleosides -

LC088 - Analysis of Nucleobases and Nucleosides -

LC087 - Analysis of Coenzyme A (CoA) -

LC086 - Analysis of Antiviral drugs -

LC085 - Analysis of Antiviral drug nucleosides -

LC084 - Analysis of Antihistamines -

LC083 - Analysis of Antidepressants -

LC082 - Analysis of phytosterols -

LC073 - Analysis of Yohimbine Hydrochloride(Under the Condition of USP41-NF36,Yohimbine Injection, ASSAY) -

LC072 - Analysis of Vitamin K１ (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PHYTONADIONE) -

LC071 - Analysis of Acetaminophen(Under the Condition of USP41-NF36, Acetaminophen Oral Solution, ASSAY) -

LC068 - Analysis of Gliclazide (Under the Condition of the draft for Japanese Pharmacopoeia, Gliclazide Tablets, ASSAY) -

LC067 - Analysis of Rebamipide (Under the Condition of the Japanese Pharmacopoeia 18th, Rebamipide, Purity (4) Related Substances -

LC066 - Analysis of Cidofovir (Under the Condition of USP43-NF38, Cidofovir, ASSAY) -

LC065 - Analysis of Vitamin E (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 1) -

LC064 - Analysis of Pioglitazone Hydrochloride and Glimepiride (Under the Condition of the Japanese Pharmacopoeia 18th, Pioglitazone Hydrochloride and Glimepiride Tablets, ASSAY(2)Glimepiride) -

LC063 - Analysis of Pioglitazone Hydrochloride and Glimepiride (Under the Condition of the Japanese Pharmacopoeia 18th, Pioglitazone Hydrochloride and Glimepiride Tablets, ASSAY(1)Pioglitazone Hydrochloride) -

LC062 - Analysis of Azithromycin (Under the Condition of USP NF 2025 Issue 2 Mar, Azithromycin, DISSOLUTION) -

LC061 - Analysis of Azithromycin (Under the Condition of USP NF 2025 Issue 2 Mar, Azithromycin,ASSAY) -

LC060 - Analysis of Aspirin (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Aspirin Delayed-release Tablets, ASSAY) -

LC059 - Analysis of 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide (Under the Condition of the draft for the Japanese Pharmacopoeia 19th, Pregabalin, 1-Fluoro-2,4-dinitrophenyl-5-L-alaninamide, Assay) -

LC058 - Analysis of Folic acid (Under the Condition of USP NF 2022 ISSUE 3, <411>FOLIC ACID ASSAY,_Procedure 1) -

LC057 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol Tablets, ASSAY) -

LC056 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol, ASSAY) -

LC055 - Analysis of Dobutamine (Under the Condition of the USPNF 2023 Issue 2, Dobutamine Hydrochloride, ASSAY) -

LC054 - Analysis of Methocarbamol (Under the Condition of USP43-NF38, Methocarbamol Injection, ASSAY) -

LC051 - Analysis of Vitamin C (Under the Condition of USP41-NF36, Vitamin C ASSAY,PROCEDURE 1) -

LC050 - Analysis of Vitamin E (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 3) -

LC049 - Analysis of Vitamin E (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Vitamin E_Method 2) -

LC047 - Analysis of Homocysteine -

LC045 - Analysis of Catecholamines -

LC044 - Analysis of Calcium Pantothenate (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Calcium Pantothenate, Method1) -

LC043 - Analysis of Semaglutide and Tirzepatide -

LC041 - Analysis of Nicotinamide,Pyridoxine Hydrochloride,Riboflavin,and Thiamine hydrochloride_Method1 (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin or Niacinamide,Pyridoxine Hydrochloride,Riboflavin,and Thiamine_ Method1) -

LC038 - Analysis of Brilliant Green and Methylene Blue -

LC037 - Analysis of Amlodipine Besilate (Under the Condition of the Japanese Pharmacopoeia 18th, Amlodipine Besilate, Purity(2) Related Substances) -

LC036 - Analysis of Zonisamide (Under the Condition of USP41-NF36, Zonisamide Compounded Oral Suspension, ASSAY) -

LC035 - Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide Capsules, ASSAY) -

LC034 - Analysis of Zonisamide (Under the Condition of USP43-NF38, Zonisamide, ASSAY) -

LC033 - Analysis of D‐Biotin (Under the Condition of USP43-NF38, Oil- and Water-Soluble Vitamins Minerals Tablets,BIOTIN_Method 3) -

LC029 - Analysis of Riboflavin (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,RIBOFLAVIN_Method 2) -

LC028 - Analysis of Pyridoxine hydrochloride (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,PYRIDOXINE HYDROCHLORIDE_Method 2) -

LC027 - Analysis of Nicotinamide (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,NIACINAMIDE_Method 2) -

LC026 - Analysis of Nicotinic acid (Under the Condition of USP41-NF36, Oil- and Water-Soluble Vitamins Capsules,Niacin_Method 2) -

LC025 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone Tablets, ASSAY) -

LC024 - Analysis of Eplerenone (Under the Condition of draft for USP, Eplerenone, ASSAY) -

LC023 - Analysis of Lansoprazole (Under the Condition of the USP41-NF36, Lansoprazole Compounded Oral Suspension, ASSAY) -

LC022 - Analysis of Ursodeoxycholic acid (Under the Condition of the Japanese Pharmacopoeia 18th, Ursodeoxycholic acid Tablets, Ursodeoxycholic acid Granules) -

LC021 - Analysis of Cyanocobalamin (Under the Condition of USP4１-NF3６, Oil- and Water-Soluble Vitamins Capsules,Cyanocobalamin_Method1) -

LC019 - Analysis of Aspartame and L-α-Aspartyl-D-phenylalanine Methyl Ester -

LC018 - Analysis of L-α-Aspartyl-D-phenylalanine Methyl Ester (Japan’s Standards and Specifications for Food Additives (10th ed.), Aspartame, Purity(5)) -

LC017 - Analysis of Itraconazole (Under the Condition of Japanese Pharmacopoeia 18th, Itraconazole, Purity(2) Related substances) -

LC016 - Analysis of Itraconazole (Under the Condition of USP-NF 2021 Issue 2, Itraconazole Capsules, ASSAY) -

LC015 - Analysis of Itraconazole (Under the draft for USP, Itraconazole Oral Solution, ASSAY) -

LC014 - Analysis of Itraconazole (Under the Condition of USP43-NF38, Itraconazole, ASSAY) -

LC013 - Analysis of Bleomycin sulfate -

LC010 - Analysis of Imazalil (Under the Condition of food additive analysis method in food, Imazalil) -

LC009 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -

LC008 - Analysis of Ketotifen Fumarate (Under the Condition of USP-NF 2024 Issue 3, Ketotifen Fumarate, ASSAY) -

LC006 - Analysis of Benzoyl Peroxide（Under the Condition of food additive analysis method in food, Benzoyl peroxide) -

LC005 - Carbamazepine -

LC004 - Analysis of Urea and Thiourea -

LC002 - Analysis of Phenazopyridine hydrochloride -

LB991 - Analysis of Progestrone and Methyltestrone -

LB990 - Analysis of Xylazine -

LB989 - Analysis of Xylazine -

LB988 - Analysis of Xylazine -

LB987 - Analysis of Xylazine -

LB986 - Analysis of Ganciclovir -

LB985 - Analysis of Sumatriptan -

LB984 - Analysis of Sumatriptan -

LB983 - Analysis of Lornoxicam -

LB982 - Analysis of Ofloxacin -

LB981 - Analysis of Ofloxacin -